好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

IPX066 Dose Conversion from Immediate-Release Carbidopa-Levodopa, Carbidopa-Levodopa+Entacapone, and Controlled-Release Carbidopa-Levodopa in Patients with Advanced Parkinson's Disease (PD)
Movement Disorders
(-)
080
Authors/Disclosures
Ann F. Hsu, PhD, PharmD (Lifemax Laboratories, Inc.)
PRESENTER
No disclosure on file
No disclosure on file
Sherron H. Kell, MD (Impax Laboratories, Inc.) No disclosure on file
Robert P. Rubens, MD, MBA, FAAN, FAAN (NeuroDevMA Consulting, Inc.) Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Suneel K. Gupta, PhD No disclosure on file
Paul Matthews, MD (Imperial College, London) No disclosure on file